Ignite Creation Date:
2025-12-25 @ 12:24 AM
Ignite Modification Date:
2026-02-22 @ 4:13 AM
Study NCT ID:
NCT01283958
Status:
COMPLETED
Last Update Posted:
2011-01-26
First Post:
2011-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D004541', 'term': 'Eisenmenger Complex'}], 'ancestors': [{'id': 'D006330', 'term': 'Heart Defects, Congenital'}, {'id': 'D018376', 'term': 'Cardiovascular Abnormalities'}, {'id': 'D002318', 'term': 'Cardiovascular Diseases'}, {'id': 'D006331', 'term': 'Heart Diseases'}, {'id': 'D000013', 'term': 'Congenital Abnormalities'}, {'id': 'D009358', 'term': 'Congenital, Hereditary, and Neonatal Diseases and Abnormalities'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'RETROSPECTIVE', 'observationalModel': 'CASE_ONLY'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 12}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2007-09'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2010-05', 'completionDateStruct': {'date': '2010-05', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2011-01-25', 'studyFirstSubmitDate': '2011-01-25', 'studyFirstSubmitQcDate': '2011-01-25', 'lastUpdatePostDateStruct': {'date': '2011-01-26', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2011-01-26', 'type': 'ESTIMATED'}}, 'conditionsModule': {'keywords': ["Iloprost, Eisenmenger's syndrome"], 'conditions': ["Eisenmenger's Syndrome"]}, 'descriptionModule': {'briefSummary': "Identification of the pathophysiology associated with Eisenmenger's syndrome has led to the evaluation of targeted therapies. Iloprost, a prostacyclin analogue, is one such targeted therapy used in patients with Eisenmenger's syndrome. The purpose of our study is to assess the effects of inhaled iloprost on patients with Eisenmenger's syndrome."}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['CHILD', 'ADULT', 'OLDER_ADULT'], 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': "12 patients with Eisenmenger's syndrome diagnosed by right side cardiac catheterization", 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion Criteria:\n\n* patients with Eisenmenger's syndrome diagnosed by right side cardiac catheterization\n\nExclusion Criteria:"}, 'identificationModule': {'nctId': 'NCT01283958', 'briefTitle': 'The Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome', 'organization': {'class': 'OTHER', 'fullName': 'Gachon University Gil Medical Center'}, 'officialTitle': 'Study of the Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome', 'orgStudyIdInfo': {'id': 'no sponsor'}}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Gachon University Gil Medical Center', 'class': 'OTHER'}, 'responsibleParty': {'oldNameTitle': 'Song I Yang', 'oldOrganization': 'Gil Hospital, Gachon University of Medicine'}}}}